ArticleInternational journal of hematology2015

Combined use of bortezomib, cyclophosphamide, and dexamethasone induces favorable hematological and organ responses in Japanese patients with amyloid light-chain amyloidosis: a single-institution retrospective study.

Yoshitaka Kikukawa et al.PubMed ↗Publisher ↗

No numbers read from the abstract.